Today's news roundup covers Dictate.IT's new AI clinical assistant and an ORCHA-approved gardening app to support mental wellbeing.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Helicore's most advanced asset, HCR-188, is a clinical stage monoclonal antibody (mAb) designed to bind GIP. The company's ...

A serial entrepreneur and a promising drug emerge from failed companies to pursue subsets of obesity patients, with or ...

Helicore, which is developing a GIP-blocking antibody, is the fourth obesity drug developer to receive funding from Versant ...